DOCSLIB.ORG

Trifluoromethanesulfonate CAS Number [34946- M10004422 82-2] 5 G 104-Eur Molekula

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Trifluoromethanesulfonate CAS Number [34946- M10004422 82-2] 5 G 104-Eur Molekula Copper(II) trifluoromethanesulfonate CAS Number [34946- M10004422 82-2] 5 G 104-Eur Molekula M10018520 1,1,3,3-Tetramethylguanidine CAS Number [80-70-6] 100 G 88-Eur Molekula M10019087 SDS (Sodium dodecyl sulfate) CAS Number [151-21-3] 1KG 166-Eur Molekula 2-Amino-6-bromo-4-methoxyphenol CAS Number M10020093 [206872-01-7] 1 G 290-Eur Molekula M10028373 1-Methylimidazole CAS Number [616-47-7] 500 G 166-Eur Molekula M10036472 2-Ethoxypyridine CAS Number [14529-53-4] 1 G 290-Eur Molekula 1,4-Cyclohexanedione monoethylene acetal (1,4- M10084798 Dioxaspiro(4.5)decan-8-one) CAS Number [4746-97-8] 100 G 352-Eur Molekula 3-Bromo-2-methylpyridine (3-Bromo-2-picoline) CAS recom M10097630 Number [38749-79-0] 1 G 352-Eur Molekula binant M10098130 Phenetole CAS Number [103-73-1] 500 G 104-Eur Molekula Decyltrimethylammonium bromide CAS Number [2082-84- M10099473 0] 100 G 197-Eur Molekula 2-Bromo-5-nitro-4-picoline (2-Bromo-4-methyl-5- recom M10112218 nitropyridine) CAS Number [23056-47-5] 1 G 414-Eur Molekula binant M10116371 Alkali blue 6B (C.I. 42750) CAS Number [30586-13-1] 25 G 88-Eur Molekula M10123276 Catechol (1,2-Dihydroxybenzene) CAS Number [120-80-9] 1KG 98-Eur Molekula cat M10127541 Mycophenolic acid CAS Number [24280-93-1] 250 MG 275-Eur Molekula M10131014 Mycophenolic acid CAS Number [24280-93-1] 1 G 662-Eur Molekula M10131619 Cordycepin CAS Number [73-03-0] 5 MG 120-Eur Molekula EDAC hydrochloride (N-(3-Dimethylaminopropyl)-N'- ethylcarbodiimide hydrochloride) CAS Number [25952-53- M10138870 8] 25 G 197-Eur Molekula EDAC hydrochloride (N-(3-Dimethylaminopropyl)-N'- ethylcarbodiimide hydrochloride) CAS Number [25952-53- M10152267 8] 100 G 507-Eur Molekula M10166694 DTT (Dithiothreitol) CAS Number [3483-12-3] 25 G 166-Eur Molekula MUG (4-Methylumbelliferyl-beta-D-glucuronide) CAS M10176050 Number [6160-80-1] 1 G 228-Eur Molekula M10189803 Kanamycin sulfate CAS Number [70560-51-9] 5 G 92-Eur Molekula N,N-Diethylnicotinamide (Nikethamide Ph.Eur) CAS M10194894 Number [59-26-7] 100 G 120-Eur Molekula M10198015 4-n-Propylphenol CAS Number [645-56-7] 25 G 228-Eur Molekula M10206171 Phleomycin CAS Number [11006-33-0] 100 MG 507-Eur Molekula M10211191 2,4-Dichloro-5-methylpyrimidine CAS Number [1780-31-0] 5 G 197-Eur Molekula M10221265 Kanamycin sulfate CAS Number [70560-51-9] 25 G 197-Eur Molekula M10228557 2-Vinylpyridine CAS Number [100-69-6] 100ML 80-Eur Molekula HBTU (o-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium M10232628 hexafluorophosphate) CAS Number [94790-37-1] 25 G 275-Eur Molekula 4-Benzyloxyaniline hydrochloride CAS Number [51388-20- M10239089 6] 100 G 110-Eur Molekula HBTU (o-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium M10239147 hexafluorophosphate) CAS Number [94790-37-1] 5 G 104-Eur Molekula TBTU (o-Benzotriazol-1-yl-N,N,N',N'-tetramethyluronium M10242506 tetrafluoroborate) CAS Number [125700-67-6] 5 G 104-Eur Molekula rat TBTU (o-Benzotriazol-1-yl-N,N,N',N'-tetramethyluronium M10255546 tetrafluoroborate) CAS Number [125700-67-6] 25 G 275-Eur Molekula rat 4,6-Dimethoxy-2-methylthiopyrimidine CAS Number M10259200 [90905-46-7] 5 G 259-Eur Molekula Thimerosal (2-(Ethylmercuriomercapto)benzoic acid M10293723 sodium salt) CAS Number [54-64-8] 25 G 166-Eur Molekula M10298788 2,5-Diaminobenzenesulfonic acid CAS Number [88-45-9] 100 G 120-Eur Molekula M10304883 Cefotaxime sodium salt CAS Number [64485-93-4] 5 G 584-Eur Molekula Thimerosal (2-(Ethylmercuriomercapto)benzoic acid M10311822 sodium salt) CAS Number [54-64-8] 100 G 414-Eur Molekula EEDQ (2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline) M10325546 CAS Number [16357-59-8] 25 G 120-Eur Molekula M10335385 Acetylthiocholine iodide CAS Number [1866-15-5] 5 G 102-Eur Molekula M10340286 Orange G (C.I.16230) CAS Number [1936-15-8] 25 G 83-Eur Molekula EEDQ (2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline) M10354315 CAS Number [16357-59-8] 100 G 275-Eur Molekula 2-Fluoro-5-trifluoromethylpyridine CAS Number [69045- M10354620 82-5] 1 G 166-Eur Molekula ADA (N-(-2-Acetamido)iminodiacetic acid) CAS Number M10361595 [26239-55-4] 100 G 104-Eur Molekula ADA (N-(-2-Acetamido)iminodiacetic acid) CAS Number M10368846 [26239-55-4] 500 G 290-Eur Molekula CHAPS (3-((3- Cholamidopropyl)dimethylammonio)propanesulfonate) M10381024 CAS Number [75621-03-3] 5 G 104-Eur Molekula M10410440 Fluorescein diacetate CAS Number [596-09-8] 5 G 88-Eur Molekula elisa M10432251 (2-Methoxyphenyl)acetonitrile CAS Number [7035-03-2] 100 G 120-Eur Molekula 4-Amino-1-naphthol hydrochloride CAS Number [5959-56- M10434262 8] 5 G 135-Eur Molekula CHAPS (3-((3- Cholamidopropyl)dimethylammonio)propanesulfonate) M10436710 CAS Number [75621-03-3] 25 G 275-Eur Molekula di-Sodium hydrogen phosphate dihydrate CAS Number M10447063 [10028-24-7] 1KG 88-Eur Molekula rat HEPES (4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic M10466417 acid) CAS Number [7365-45-9] 500 G 228-Eur Molekula 2,6-Dimethyl-4-hydroxypyridine CAS Number [13603-44- M10473028 6] 25 G 290-Eur Molekula 2-Amino-3-chlorobenzoic acid (3-Chloroanthranilic acid) M10490612 CAS Number [6388-47-2] 1 G 88-Eur Molekula MES Buffer grade (2-Morpholinoethanesulfonic acid) CAS M10491143 Number [4432-31-9] 100 G 88-Eur Molekula MES Buffer grade (2-Morpholinoethanesulfonic acid) CAS M10493898 Number [4432-31-9] 500 G 228-Eur Molekula MOPS (3-Morpholinopropanesulfonic acid) CAS Number M10494333 [1132-61-2] 100 G 88-Eur Molekula M10504669 Ethyl 3-methyl-4-oxocrotonate CAS Number [62054-49-3] 100 G 160-Eur Molekula M10513643 4-Fluorobenzyl alcohol CAS Number [459-56-3] 25 G 104-Eur Molekula M10517846 1-(2-Pyridylazo)-2-naphthol CAS Number [85-85-8] 5 G 110-Eur Molekula M10530364 4-(2-Hydroxyethyl)morpholine CAS Number [622-40-2] 500 G 135-Eur Molekula M10531227 D-(+)-chiro-Inositol CAS Number [643-12-9] 100 MG 135-Eur Molekula MOPS (3-Morpholinopropanesulfonic acid) CAS Number M10542709 [1132-61-2] 500 G 228-Eur Molekula 13-cis-Retinoic acid (Isotretinoin) CAS Number [4759-48- M10543768 2] 1 G 120-Eur Molekula PIPES (Piperazine-1,4-bis(2-ethanesulfonic acid)) CAS M10550899 Number [5625-37-6] 100 G 104-Eur Molekula M10555585 Isometheptene mucate CAS Number [7492-31-1] 100 MG 197-Eur Molekula cat M10557588 Vitamin D3 (Cholecalciferol) CAS Number [67-97-0] 5 G 135-Eur Molekula PIPES (Piperazine-1,4-bis(2-ethanesulfonic acid)) CAS M10564393 Number [5625-37-6] 500 G 290-Eur Molekula Daminozide (Succinic acid mono-(2,2-dimethylhydrazide) M10568075 CAS Number [1596-84-5] 25 G 104-Eur Molekula elisa Aldolase,from Rabbit Muscle, Ammonium sulphate polyclo M10593823 solution CAS Number [9024-52-6] 100 MG 383-Eur Molekula nal M10606407 2'-O-Methyluridine CAS Number [2140-76-3] 1 G 228-Eur Molekula M10608799 Ammonium thiocyanate CAS Number [1762-95-4] 1KG 98-Eur Molekula TRIS (Tris(hydroxymethyl)aminomethane) CAS Number M10622483 [77-86-1] 1KG 104-Eur Molekula TRIS (Tris(hydroxymethyl)aminomethane) CAS Number M10626717 [77-86-1] 5KG 290-Eur Molekula BIS-TRIS (Bis(2-hydroxyethyl)amino- M10631082 tris(hydroxymethyl)methane) CAS Number [6976-37-0] 100 G 104-Eur Molekula BIS-TRIS (Bis(2-hydroxyethyl)amino- M10631931 tris(hydroxymethyl)methane) CAS Number [6976-37-0] 500 G 275-Eur Molekula M10637269 TRIS hydrochloride CAS Number [1185-53-1] 1KG 166-Eur Molekula M10642779 4-Trifluoromethoxyaniline CAS Number [461-82-5] 5 G 80-Eur Molekula Ammonium iron(III) sulfate dodecahydrate CAS Number M10691849 [7783-83-7] 1KG 110-Eur Molekula rat M10696487 TRIS hydrochloride CAS Number [1185-53-1] 5KG 538-Eur Molekula 3-Acetoxy-2-methylbenzoic acid CAS Number [168899-58- M10703192 9] 5 G 135-Eur Molekula TAPS (N-(Tris(hydroxymethyl)methyl)-3- M10707843 aminopropanesulfonic acid) CAS Number [29915-38-6] 100 G 88-Eur Molekula M10726608 Acetylthiocholine iodide CAS Number [1866-15-5] 25 G 275-Eur Molekula M10731817 2-Chloro-5-nitrobenzaldehyde CAS Number [6361-21-3] 25 G 135-Eur Molekula X-Gal (5-Bromo-4-chloro-3-indolyl-beta-D- M10742126 galactopyranoside) CAS Number [7240-90-6] 1 G 135-Eur Molekula X-Gal (5-Bromo-4-chloro-3-indolyl-beta-D- M10746271 galactopyranoside) CAS Number [7240-90-6] 5 G 414-Eur Molekula IPTG (Isopropyl-beta-D-thiogalactopyranoside) CAS M10749693 Number [367-93-1] 5 G 151-Eur Molekula IPTG (Isopropyl-beta-D-thiogalactopyranoside) CAS M10750870 Number [367-93-1] 25 G 460-Eur Molekula M10760576 Glycine CAS Number [56-40-6] 1KG 88-Eur Molekula M10761225 Quercetin CAS Number [117-39-5] 1 G 135-Eur Molekula M10765509 Propionamide CAS Number [79-05-0] 25 G 88-Eur Molekula M10776312 Voglibose CAS Number [83480-29-9] 1 G 197-Eur Molekula M10795755 Glycine CAS Number [56-40-6] 5KG 228-Eur Molekula M10797071 DL-Asparagine monohydrate CAS Number [3130-87-8] 100 G 104-Eur Molekula rat TES (N-(Tris(hydroxymethyl)methyl)-2- M10800473 aminoethanesulfonic acid) CAS Number [7365-44-8] 100 G 120-Eur Molekula M10806584 4-Iodo-2-methylaniline CAS Number [13194-68-8] 5 G 166-Eur Molekula M10809364 Quinoline-8-boronic acid CAS Number [86-58-8] 1 G 507-Eur Molekula TES (N-(Tris(hydroxymethyl)methyl)-2- M10813371 aminoethanesulfonic acid) CAS Number [7365-44-8] 500 G 352-Eur Molekula M10820769 Imidazole CAS Number [288-32-4] 500 G 88-Eur Molekula M10826593 Imidazole CAS Number [288-32-4] 2x5KG 212-Eur Molekula M10832312 Boric acid CAS Number [10043-35-3] 1KG 67-Eur Molekula M10845977 2'-Deoxyuridine CAS Number [951-78-0] 100 G 430-Eur Molekula M10857691 5-Chloro-2-nitrobenzotrifluoride CAS Number [118-83-2] 25 G 135-Eur Molekula M10877591 4-Piperidinopiperidine CAS Number [4897-50-1] 5 G 166-Eur Molekula M10879536 D-Cycloserine CAS Number [68-41-7] 5 G 228-Eur Molekula M10880695 D-Cycloserine CAS Number [68-41-7] 1 G 98-Eur Molekula O-(5-Norbornene-2,3-dicarboximido)-tetramethyluronium M10887351 tetrafluoroborate (TNTU) CAS Number [125700-73-4] 5 G 166-Eur Molekula rat Bromocresol Purple sodium salt CAS Number [62625-30- M10922214 3] 25 G 135-Eur Molekula M10930037 3-Chloro-2-fluoroaniline CAS Number [2106-04-9] 1 G 321-Eur Molekula M10932601 N,N'-Carbonyldiimidazole (CDI) CAS Number [530-62-1] 25 G 104-Eur Molekula M10934429 L-Ascorbic acid (Vitamin C) CAS Number [50-81-7] 100 G 86-Eur Molekula M10944806 N,N'-Carbonyldiimidazole (CDI) CAS Number [530-62-1] 100 G 243-Eur Molekula Coomassie brilliant blue R-250 (C.I.
Load more

Recommended publications
  • Thermodynamic Quantities for the Ionization Reactions of Buffers
    Thermodynamic Quantities for the Ionization Reactions of Buffers Robert N. Goldberg,a… Nand Kishore,b… and Rebecca M. Lennen Biotechnology Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899 ͑Received 21 June 2001; accepted 16 September 2001; published 24 April 2002͒ This review contains selected values of thermodynamic quantities for the aqueous ionization reactions of 64 buffers, many of which are used in biological research. Since the aim is to be able to predict values of the ionization constant at temperatures not too far from ambient, the thermodynamic quantities which are tabulated are the pK, standard ⌬ ؠ ⌬ molar Gibbs energy rG , standard molar enthalpy rH°, and standard molar heat ca- ؠ ⌬ pacity change rC p for each of the ionization reactions at the temperature T ϭ298.15 K and the pressure pϭ0.1 MPa. The standard state is the hypothetical ideal solution of unit molality. The chemical name͑s͒ and CAS registry number, structure, empirical formula, and molecular weight are given for each buffer considered herein. The selection of the values of the thermodynamic quantities for each buffer is discussed. © 2002 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. Key words: buffers; enthalpy; equilibrium constant; evaluated data; Gibbs free energy; heat capacity; ionization; pK; thermodynamic properties. Contents 7.19. CAPSO.............................. 263 7.20. Carbonate............................ 264 7.21. CHES............................... 264 1. Introduction................................ 232 7.22. Citrate............................... 265 2. Thermodynamic Background.................. 233 7.23. L-Cysteine............................ 268 3. Presentation of Data......................... 234 7.24. Diethanolamine........................ 270 4. Evaluation of Data. ........................ 235 7.25. Diglycolate..........................
    [Show full text]
  • Buffers a Guide for the Preparation and Use of Buffers in Biological Systems Calbiochem® Buffers a Guide for the Preparation and Use of Buffers in Biological Systems
    Buffers A guide for the preparation and use of buffers in biological systems Calbiochem® Buffers A guide for the preparation and use of buffers in biological systems Chandra Mohan, Ph.D. EMD, San Diego, California © EMD, an affiliate of Merck KGaA, Darmstadt, Germany. All rights reserved. A word to our valued customers We are pleased to present to you the newest edition of Buffers: A Guide for the Preparation and Use of Buffers in Biological Systems. This practical resource has been especially revamped for use by researchers in the biological sciences. This publication is a part of our continuing commitment to provide useful product information and exceptional service to you, our customers. You will find this booklet a highly useful resource, whether you are just beginning your research work or training the newest researchers in your laboratory. Over the past several years, EMD Biosciences has clearly emerged as a world leader in providing highly innovative products for your research needs in Signal Transduction, including the areas of Cancer Biology, Alzheimer’s Disease, Diabetes, Hypertension, Inflammation, and Apoptosis. Please call us today for a free copy of our LATEST Catalog that includes tools for signal transduction and life science research. If you have used our products in the past, we thank you for your support and confidence in our products, and if you are just beginning your research career, please call us and give us the opportunity to demonstrate our exceptional customer and technical service. Corrine Fetherston Sr. Director, Marketing ii Table of Contents: Why does Calbiochem® Biochemicals Publish a Booklet on Buffers? .
    [Show full text]
  • Biological Buffers and Ultra Pure Reagents
    Biological Buffers and Ultra Pure Reagents Are MP Buffers in your corner? One Call. One Source. A World of Ultra Pure Biochemicals. www.mpbio.com Theoretical Considerations Since buffers are essential for controlling the pH in many Since, under equilibrium conditions, the rates of dissociation and biological and biochemical reactions, it is important to have a association must be equal, they may be expressed as: basic understanding of how buffers control the hydrogen ion concentration. Although a lengthy, detailed discussion is impractical, + - k1 (HAc) = k2 (H ) (Ac ) some explanation of the buffering phenomena is important. Or Let us begin with a discussion of the equilibrium constant (K) for + - weak acids and bases. Acids and bases which do not completely k1 = (H ) (Ac ) dissociate in solution, but instead exist as an equilibrium mixture of k (HAc) undissociated and dissociated species, are termed weak acids and 2 bases. The most common example of a weak acid is acetic acid. If we now let k1/k2 = Ka , the equilibrium constant, the equilibrium In solution, acetic acid exists as an equilibrium mixture of acetate expression becomes: ions, hydrogen ions, and undissociated acetic acid. The equilibrium between these species may be expressed as follows: + - Ka = (H ) (Ac ) k1 (HAc) + - HAc ⇌ H + Ac which may be rearranged to express the hydrogen ion concentration k2 in terms of the equilibrium constant and the concentrations of undissociated acetic acid and acetate ions as follows: where k1 is the dissociation rate constant of acetic acid to acetate and hydrogen ions and k is the association rate constant of the ion 2 (H+) = K (HAc) species to form acetic acid.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0030594 A1 ABRAMS Et Al
    US 2016.0030594A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0030594 A1 ABRAMS et al. (43) Pub. Date: Feb. 4, 2016 (54) ANTIBODY DRUG CONJUGATES Related U.S. Application Data (71) Applicants: Tinya ABRAMS, Acton, MA (US); (60) Provisional application No. 61/793,641, filed on Mar. Steven COHEN, San Diego, CA (US); 15, 2013. Christie P. FANTON, Oakland, CA EEEE): Publication Classification Kathy MILLER, San Francisco, CA (51) Int. Cl (US); Siew Ho SCHLEYER, El Cerrito, we CA (US); Kathrin Ulrike g 7. :08: TISSOT-DAGUETTE, Planegg (DE) A647/12 (2006.01) (72) Inventors: Tinya ABRAMS, Acton, MA (US); A647/26 (2006.01) Steven COHEN, San Diego, CA (US); A 6LX3/537 (2006.01) Christie P. FANTON, Oakland, CA A6II 45/06 (2006.01) (US); Catrin FINNER, Neuried (DE); (52) U.S. Cl. Thomas HUBER, Allschwil (CH): CPC. A61 K47/48561 (2013.01); A61K 47/48384 Kathy MILLER, San Francisco, CA (2013.01); A61 K3I/537 (2013.01); A61 K (US); Siew Ho SCHLEYER, El Cerrito, 45/06 (2013.01); A61 K47/12 (2013.01); A61 K CA (US); Kathrin Ulrike 47/26 (2013.01); A61 K47/4863 (2013.01); TISSOT-DAGUETTE, Planegg (DE) A61K47/48592 (2013.01); A61K 47/48615 (2013.01); C07K 16/32 (2013.01); C07K (21) Appl. No.: 14/774,512 231 7/565 (2013.01); C07K 231 7/24 (2013.01) (86). PCT No.: PCT/US14/24597 The present invention relates to anti-cKIT antibodies, anti S371 (c)(1), body fragments, antibody drug conjugates, and their uses for (2) Date: Sep.10, 2015 the treatment of cancer.
    [Show full text]
  • 083 Toxicity of Ibotenic Acid and Muscimol Containing Mushrooms Reported to a Regional Poison Control Center from 2002-2016 Mich
    083 Toxicity of ibotenic acid and muscimol containing mushrooms reported to a regional poison control center from 2002-2016 Michael Moss 1,2 , Robert Hendrickson 1,2 1Oregon Health and Science University, Portland, OR, USA, 2Oregon Poison Center, Portland, OR, USA Background: Amanita muscaria (AM) and Amanita pantherina (AP) contain ibotenic acid and muscimol and may cause both excitatory and sedating symptoms. A "typical" syndrome of accidental ingestion with CNS depression in adults and CNS excitation in children and a paucity of GI symptoms or respiratory depression are based on relatively few reported cases with these mushrooms in North America. Research Question: What are the clinical effects of ibotenic acid/muscimol containing mushroom toxicity? Methods: Retrospective review of ingestions of ibotenic acid/muscimol containing mushrooms reported to a regional poison center from 2002-2016. Cases were included if identification was made by a mycologist or if AM was described as a red/orange mushroom with white spots. Results: Thirty-five cases met inclusion criteria. There were 24 cases of AM, 10 AP, and 1 A. aprica. Reason for ingestion included foraging (12), recreational (5), accidental (12), therapeutic (1), and self- harm (1). Of the accidental pediatric ingestions 4 (25%) were symptomatic. None of the children with a symptomatic ingestion of AM required admission. A 3-year old male who ingested AP developed vomiting, agitation, and lethargy. He was intubated and had a 3-day ICU stay. There were 25 symptomatic patients in total. All but one developed symptoms within 6 hours. Duration of symptoms was: <6 hours (6, 24%), 6-24 hours (15, 60%), >24 hours (1, 4%), and unreported (3, 12%).
    [Show full text]
  • Phytochem Referenzsubstanzen
    High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.286. ABIETIC ACID Sylvic acid [514-10-3] 302.46 C20H30O2 01.030. L-ABRINE N-a-Methyl-L-tryptophan [526-31-8] 218.26 C12H14N2O2 Merck Index 11,5 01.031. (+)-ABSCISIC ACID [21293-29-8] 264.33 C15H20O4 Merck Index 11,6 01.032. (+/-)-ABSCISIC ACID ABA; Dormin [14375-45-2] 264.33 C15H20O4 Merck Index 11,6 01.002. ABSINTHIN Absinthiin, Absynthin [1362-42-1] 496,64 C30H40O6 Merck Index 12,8 01.033. ACACETIN 5,7-Dihydroxy-4'-methoxyflavone; Linarigenin [480-44-4] 284.28 C16H12O5 Merck Index 11,9 01.287. ACACETIN Apigenin-4´methylester [480-44-4] 284.28 C16H12O5 01.034. ACACETIN-7-NEOHESPERIDOSIDE Fortunellin [20633-93-6] 610.60 C28H32O14 01.035. ACACETIN-7-RUTINOSIDE Linarin [480-36-4] 592.57 C28H32O14 Merck Index 11,5376 01.036. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- a-D-Glucosamine pentaacetate 389.37 C16H23NO10 ACETYL-a-D-GLUCOPYRANOSE 01.037. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- b-D-Glucosamine pentaacetate [7772-79-4] 389.37 C16H23NO10 ACETYL-b-D-GLUCOPYRANOSE> 01.038. 2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL- Acetochloro-a-D-glucosamine [3068-34-6] 365.77 C14H20ClNO8 a-D-GLUCOPYRANOSYLCHLORIDE - 1 - High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.039.
    [Show full text]
  • WO 2018/185618 Al 11 October 2018 (11.10.2018) W !P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/185618 Al 11 October 2018 (11.10.2018) W !P O PCT (51) International Patent Classification: (74) Agent: NOVARTIS AG; Lichtstrasse 35, 4056 Basel A61K 47/68 (2017.01) A61P 35/00 (2006.01) (CH). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/IB20 18/05215 1 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (22) International Filing Date: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, 28 March 2018 (28.03.2018) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (25) Filing Language: English HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (26) Publication Langi English MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (30) Priority Data: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 62/480,972 03 April 2017 (03.04.2017) US SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant: NOVARTIS AG [CH/CH]; Lichtstrasse 35, 4056 Basel (CH). (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (72) Inventors: ANTONAKOS, Brandon Peter; Novartis In GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, stitutes for BioMedical Research, Inc., 250 Massachu UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, setts Avenue, Cambridge, Massachusetts 02139 (US).
    [Show full text]
  • Gabaergic Ventrolateral Pre‑Optic Nucleus Neurons Are Involved in the Mediation of the Anesthetic Hypnosis Induced by Propofol
    MOLECULAR MEDICINE REPORTS 16: 3179-3186, 2017 GABAergic ventrolateral pre‑optic nucleus neurons are involved in the mediation of the anesthetic hypnosis induced by propofol JIE YUAN1,2, ZHUXIN LUO2, YU ZHANG2, YI ZHANG1,2, YUAN WANG1,2, SONG CAO2,3, BAO FU2,4, HAO YANG2, LIN ZHANG2, WENJING ZHOU2 and TIAN YU2 1Department of Anesthesiology, Affiliated Hospital of Zunyi Medical College;2 Guizhou Key Laboratory of Anesthesia and Organ Protection, Zunyi Medical College; 3Department of Pain, Affiliated Hospital of Zunyi Medical College; 4Department of Intense Care Unit, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, P.R. China Received February 9, 2017; Accepted July 13, 2017 DOI: 10.3892/mmr.2017.7035 Abstract. Intravenous anesthetics have been used clinically level, there are dozens of molecules known to be general to induce unconsciousness for seventeen decades, however the anesthetic targets, including a number of ion channels (2), mechanism of anesthetic-induced unconsciousness remains gap-junction channels (3), and G protein-coupled receptors (4). to be fully elucidated. It has previously been demonstrated It's remarkable that there is no single molecular target shared that anesthetics exert sedative effects by acting on endoge- by all general anesthetics (1). Therefore, effects of general nous sleep-arousal circuits. However, few studies focus on anesthetics must be comprehended in the context of network the ventrolateral pre-optic (VLPO) to locus coeruleus (LC) connectivity. sleep-arousal pathway. The present study aimed to investigate There are similarities between general anesthesia and if VLPO is involved in unconsciousness induced by propofol. natural sleep. Imaging studies have shown some paral- The present study additionally investigated if the inhibitory lels between the anesthetized brain and the brain during effect of propofol on LC neurons was mediated by activating deep non-rapid-eye-movement (NREM) sleep (5,6).
    [Show full text]
  • Pharmacological Studies on a Locust Neuromuscular Preparation
    J. Exp. Biol. (1974). 6i, 421-442 421 *&ith 2 figures in Great Britain PHARMACOLOGICAL STUDIES ON A LOCUST NEUROMUSCULAR PREPARATION BY A. N. CLEMENTS AND T. E. MAY Woodstock Research Centre, Shell Research Limited, Sittingbourne, Kent {Received 13 March 1974) SUMMARY 1. The structure-activity relationships of agonists of the locust excitatory neuromuscular synapse have been reinvestigated, paying particular attention to the purity of compounds, and to the characteristics and repeatability of the muscle response. The concentrations of compounds required to stimu- late contractions of the retractor unguis muscle equal in force to the neurally evoked contractions provided a measure of the relative potencies. 2. Seven amino acids were capable of stimulating twitch contractions, glutamic acid being the most active, the others being analogues or derivatives of glutamic or aspartic acid. Aspartic acid itself had no excitatory activity. 3. Excitatory activity requires possession of two acidic groups, separated by two or three carbon atoms, and an amino group a to a carboxyl. An L-configuration appears essential. The w-acidic group may be a carboxyl, sulphinyl or sulphonyl group. Substitution of any of the functional groups generally causes total loss of excitatory activity, but an exception is found in kainic acid in which the nitrogen atom forms part of a ring. 4. The investigation of a wide variety of compounds revealed neuro- muscular blocking activity among isoxazoles, hydroxylamines, indolealkyl- amines, /?-carbolines, phenazines and phenothiazines. No specific antagonist of the locust glutamate receptor was found, but synaptic blocking agents of moderately high activity are reported. INTRODUCTION The study of arthropod neuromuscular physiology has been impeded by the lack of an antagonist which can be used to block excitatory synaptic transmission by a specific postsynaptic effect.
    [Show full text]
  • Stimulation of Lateral Hypothalamic Kainate Receptors Selectively Elicits Feeding Behavior
    BRAIN RESEARCH 1184 (2007) 178– 185 available at www.sciencedirect.com www.elsevier.com/locate/brainres Research Report Stimulation of lateral hypothalamic kainate receptors selectively elicits feeding behavior Stacey R. Hettesa, Theodore W. Heyming, B. Glenn Stanleyb,c,⁎ aDepartment of Biology, Wofford College, Spartanburg, SC 29303, USA bDepartment of Psychology, University of California-Riverside, Riverside, CA 92521, USA cDepartment of Cell Biology and Neuroscience, University of California-Riverside, Riverside, CA 92521, USA ARTICLE INFO ABSTRACT Article history: Glutamate and its receptor agonists, NMDA, AMPA, and KA, elicit feeding when Accepted 24 September 2007 microinjected into the lateral hypothalamus (LH) of satiated rats. However, determining Available online 2 October 2007 the relative contributions of AMPA receptors (AMPARs) and KA receptors (KARs) to LH feeding mechanisms has been difficult due to a lack of receptor selective agonists and Keywords: antagonists. Furthermore, LH injection of KA produces behavioral hyperactivity, Lateral hypothalamus questioning a role for KARs in feeding selective stimulation. In the present study, we used Feeding the KAR agonist, (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid Kainate (ATPA), which selectively binds the GluR5 subunit of KARs, to stimulate feeding, Glutamate presumably via KAR activation. Using ATPA, we tested whether: (1) LH injection of ATPA ATPA elicits feeding, (2) prior treatment with the non-selective AMPA/KAR antagonist, CNQX, iGluR suppresses ATPA-elicited feeding, and (3) LH injection of ATPA elicits behavioral patterns specific for feeding. We found that injection of ATPA (0.1 and 1 nmol) elicited an intense feeding response (e.g., 4.8±1.6 g) that was blocked by LH pretreatment with CNQX, but was unaffected by pretreatment with the AMPAR selective antagonist, GYKI 52466.
    [Show full text]
  • Biological Buffers
    AppliCations No.2 Biological Buffers Many biochemical processes are markedly impaired by even small changes in the con centrations of free H+ ions. It is therefore usually necessary to stabilise the H+ concentration in vitro by adding a suitable buffer to the medium, without, however, affecting the functioning of the system under investigation. A buffer keeps the pH of a solution constant by taking up protons that are released during reactions, or by r eleasing protons when they are consumed by reactions. This handout summarizes the most commonly used buffer substances and respec- tive physical and chemical properties. Keywords Practical Tips – Preparing Buffer Solutions chemical properties Recommendations for the setting of the pH value of a buffer and storage conditions usefull pH range 1. Temperature Depending on the buffer substance, its pH may vary with temperature. It is therefore advisable, as far as possible, to set the pH buffer preparation at the working temperature to be used for the investigation. For instance the physiological pH value for most mammalian cells at 37°C is between 7.0 and 7.5. The temperature dependence of a buffer system is expressed as d(pKa)/dT, which describes the change of the pKa at an increase of temperature by 1°C. 2. Titration (i) Generally, the pH value is set using NaOH/KOH or HCl. Slow addition of a strong acid or base whilst stirring vigorously avoids local high concentrations of H+ or OH– ions. If this is not done, the buffer substances may undergo chemical changes that inactivate them or modify them so that they have an inhibitory action (Ellis & Morrison 1982).
    [Show full text]
  • Ibotenic Acid SAFETY DATA SHEET Section 2. Hazards Identification Section 3. Composition/Information on Ingredients
    SAFETY DATA SHEET Page: 1 of 5 Ibotenic Acid Revision: 04/17/2018 Supersedes Revision: 02/28/2014 according to Regulation (EC) No. 1907/2006 as amended by (EC) No. 1272/2008 Section 1. Identification of the Substance/Mixture and of the Company/Undertaking 1.1 Product Code: 14584 Product Name: Ibotenic Acid Synonyms: .alpha.-amino-2,3-dihydro-3-oxo-5-isoxazoleacetic acid; NSC 204850; 1.2 Relevant identified uses of the substance or mixture and uses advised against: Relevant identified uses: For research use only, not for human or veterinary use. 1.3 Details of the Supplier of the Safety Data Sheet: Company Name: Cayman Chemical Company 1180 E. Ellsworth Rd. Ann Arbor, MI 48108 Web site address: www.caymanchem.com Information: Cayman Chemical Company +1 (734)971-3335 1.4 Emergency telephone number: Emergency Contact: CHEMTREC Within USA and Canada: +1 (800)424-9300 CHEMTREC Outside USA and Canada: +1 (703)527-3887 Section 2. Hazards Identification 2.1 Classification of the Substance or Mixture: Acute Toxicity: Oral, Category 3 2.2 Label Elements: GHS Signal Word: Danger GHS Hazard Phrases: H301: Toxic if swallowed. GHS Precaution Phrases: P264: Wash {hands} thoroughly after handling. GHS Response Phrases: P301+310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P330: Rinse mouth. GHS Storage and Disposal Phrases: Please refer to Section 7 for Storage and Section 13 for Disposal information. 2.3 Adverse Human Health Material may be irritating to the mucous membranes and upper respiratory tract. Effects and Symptoms: May be harmful by inhalation or skin absorption.
    [Show full text]